Scilex SCLX Q4 2025 Results Miss Estimates EPS 221 vs 048 Gen Z Homeownership Defies Odds Young Buyers Outpace Millennials at Same Age Indian Q4 Earnings Roundup Apollo Micro Zydus Wellness Post Profit Growth GNFC PAT Surges 88 Strides Pharma Afcons Infra Face Headwinds US Wholesale Prices Surge 60 in April Marking Sharpest Annual Gain Since 2022 Prediction Markets Face Growing Legal Challenges 16 States Pursue Action Against Platforms Chinas DeepSeek AI Claims CostEfficient Model Training Using Less Advanced Chips SpaceX Scrubs Starship Test Flight Eyes Friday Retry Amid IPO Preparations More Couples Opt for Separate Bank Accounts Financial Risks and Considerations Trump Signals Desire for Fed Chair Independence Amid Policy Divergence Skilled Trade Pay Surges 30 Challenging Traditional College Career Path Says Recruitment Giant CEO SPOT Q1 2026 Earnings Strong EPS Beat Amid Mixed Market Sentiment NEM Q1 2026 Earnings Strong EPS Beat but Shares Slide 289 ASTL Q1 2026 Earnings EPS Surges Past Estimates by 42 Stock Jumps 7 VRRM Q1 2026 Earnings EPS Beats Estimates on Strong Execution Stock Slightly Higher LE Q1 2026 Earnings Earnings Miss Weighs on Outlook HEPS Q1 2026 Earnings Negative EPS and No Revenue Disclosure Weigh on Sentiment Shares Decline 387 Guggenheim Taxable Municipal Bond Trust GBAB Sees Modest Uptick as RangeBound Trading Persists Entergy Slips Slightly Near Support Mixed Signals for Utilities CNS Pharmaceuticals CNSP Faces Selling Pressure as Shares Decline Over 5 Schneider National Inc SNDR Rallies 269 as Transport Sector Shows Renewed Momentum Optex Systems Holdings OPXS Posts Modest Gains Amid Tight Trading Range The AI Economy Reshapes the American Dream BlueCollar Skilled Trades Emerge as a Growth Sector Airgain Q1 2026 Earnings EPS Misses Estimates as Cost Pressures Weigh Equity Lifestyle Properties ELS Consolidates Near 62 After Modest 03 Decline PMTW Q1 2026 Earnings EPS Misses Estimates Amid Challenging Mortgage Market CAPL Q1 2026 Earnings Strong EPS Surprise Despite Challenging Environment ANI Pharmaceuticals Q1 2026 Earnings Major EPS Beat Belies Subdued Market Response M Q1 2026 Earnings EPS Beats Estimates by 673 as Stock Declines Chemours Q1 2026 Earnings Strong EPS Surprise Despite Ongoing Headwinds COST Q1 2026 Earnings EPS Misses Estimates Stock Declines IMMR Q3 2025 Earnings EPS Surges Past Estimates Stock Reacts Positively